Cargando…

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction

Leukocytosis is a common finding in patients with ST elevation myocardial infarction (STEMI) and portends a poor prognosis. Interleukin 1-β regulates leukopoiesis and pre-clinical studies suggest that anakinra (recombinant human interleukin-1 [IL-1] receptor antagonist) suppresses leukocytosis in my...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Buono, Marco Giuseppe, Damonte, Juan Ignacio, Trankle, Cory R., Kadariya, Dinesh, Carbone, Salvatore, Thomas, Georgia, Turlington, Jeremy, Markley, Roshanak, Canada, Justin M., Biondi‐Zoccai, Giuseppe G., Kontos, Michael C., Van Tassell, Benjamin W., Abbate, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786840/ https://www.ncbi.nlm.nih.gov/pubmed/35075216 http://dx.doi.org/10.1038/s41598-022-05374-w

Ejemplares similares

Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra
por: Golino, Michele, et al.
Publicado: (2023)

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study
por: Van Tassell, Benjamin, et al.
Publicado: (2022)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Abbate, Antonio, et al.
Publicado: (2020)

Interleukin‐1 blockade in heart failure: an on‐treatment and off‐treatment cardiorespiratory fitness analysis
por: Moroni, Francesco, et al.
Publicado: (2023)

3426 Increased Monounsaturated Fat Consumption is Associated with Improved Body Composition in Subjects with Obesity and Heart Failure with Preserved Ejection Fraction
por: Billingsley, Hayley, et al.
Publicado: (2019)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
por: Buckley, Leo F., et al.
Publicado: (2018)

3415 Percent Predicted Peak Exercise Oxygen Pulse Is a Marker of Cardiac Reserve Following Thoracic Radiotherapy
por: Canada, Justin McNair, et al.
Publicado: (2019)

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study
por: Carbone, Salvatore, et al.
Publicado: (2019)

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)

2363: Ventriculo-arterial coupling and left ventricular mechanical work in systolic and diastolic heart failure
por: Buckley, Leo, et al.
Publicado: (2018)

Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction
por: Markley, Roshanak, et al.
Publicado: (2023)

Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus
por: Marawan, Amr, et al.
Publicado: (2021)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
por: Trankle, Cory, et al.
Publicado: (2017)

2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
por: Canada, Justin M., et al.
Publicado: (2018)

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
por: Dixon, Dave L, et al.
Publicado: (2017)

2438: Dose-dependent nature of cocaine infusions on cardiovascular hemodynamics
por: Carbone, Salvatore, et al.
Publicado: (2018)

Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
por: Carbone, Salvatore, et al.
Publicado: (2017)

Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy
por: Canada, Justin M., et al.
Publicado: (2020)

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
por: Carbone, Salvatore, et al.
Publicado: (2020)

2544: Dietary polyunsaturated fatty acid consumption is associated with improved body composition in nonalcoholic steatohepatitis patients
por: Billingsley, Hayley, et al.
Publicado: (2018)

Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy
por: Canada, Justin M., et al.
Publicado: (2022)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Metabolic modulation predicts heart failure tests performance
por: Contaifer, Daniel, et al.
Publicado: (2019)

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
por: Kron, Jordana, et al.
Publicado: (2021)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer
por: Toldo, Stefano, et al.
Publicado: (2017)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation
por: Trankle, Cory, et al.
Publicado: (2016)

Cardiologic side effects of psychotropic drugs
por: Marano, Giuseppe, et al.
Publicado: (2011)

Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale
por: Samsonov, M., et al.
Publicado: (2021)

Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES)
por: Stredny, Coral M., et al.
Publicado: (2020)

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers
por: Wohlford, George F., et al.
Publicado: (2021)

Network Meta-analysis to Synthesize Evidence for Decision Making in Cardiovascular Research
por: Roever, Leonardo, et al.
Publicado: (2016)

Late Pseudoaneurysm after Manta Use for Transfemoral Aortic Valve Implantation: A Call for Caution?
por: Roever, Leonardo, et al.
Publicado: (2018)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
por: Roy, Noémi B A, et al.
Publicado: (2020)

277 Heart Failure Clinical Trial Enrollment at a Rural Satellite Hospital
por: Abbate, Antonio, et al.
Publicado: (2022)

Heart, Lung and Vessels... but brain and hands too! The case for a novel journal in the cardiovascular scholarly arena
por: Peruzzi, Mariangela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n75u5plhkjs4k16d1nsfn203t8